CN Patent

CN104968363A — Pi3k/akt抑制剂化合物与her3/egfr抑制剂化合物的组合及使用方法

Assigned to General Hospital Corp · Expires 2015-10-07 · 11y expired

What this patent protects

本发明提供包含GDC-0068或GDC-0941或其药学上可接受的盐与MEHD7945A的组合。所述组合特别适用于治疗过度增殖性病症，如癌症(例如三阴性乳腺癌)。

USPTO Abstract

本发明提供包含GDC-0068或GDC-0941或其药学上可接受的盐与MEHD7945A的组合。所述组合特别适用于治疗过度增殖性病症，如癌症(例如三阴性乳腺癌)。

Drugs covered by this patent

Patent Metadata

Patent number
CN104968363A
Jurisdiction
CN
Classification
—
Expires
2015-10-07
Drug substance claim
No
Drug product claim
No
Assignee
General Hospital Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.